IPM saw sales of Rs 15,921 crore during July.
All therapeutic categories, except anti-infectives have witnessed double digit growth.
The fastest growing categories are respiratory which grew at 22.3%, gynaecology – 24%, chemotherapy – 28.4%, urology – 22.5%, ophthalmic – 18.8%, pain – 16.9% and derma – 16.7%. The monsoon related flu-season and rebound of non-emergency surgeries, could have led to the growth of the above segments.
Augmentin of GSK, Glycomet of USV and Mixtard of Abbott, remain top-3 selling brands in India.